http://prostatecancerinfolink.net/2012/09/24/lon-term-outcomes-after-rp-as-first-line-therapy-for-men-with-ct3-disease-at-time-of-diagnosis/
Some data on the surgical outcomes for cT3 staged patients.
The free progression rates in the low 70% range are in line with most other studies.